Literature DB >> 19850662

Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit.

S A Namendys-Silva1, J A Baltazar-Torres, E Rivero-Sigarroa, J A Fonseca-Lazcano, L Montiel-López, G Domínguez-Cherit.   

Abstract

The objectives of this study were to identify risk factors associated with mortality in patients with systemic lupus erythematosus (SLE) admitted to the intensive care unit (ICU) and to evaluate the usefulness of Acute Physiologic and Chronic Health Evaluation (APACHE) II score to predict outcomes in these patients, through the use of a retrospective patient record review from a multidisciplinary intensive care unit in a teaching hospital. One hundred and four patients with SLE admitted to the ICU were included in the study. The mean age of patients was 32.44 years, 96.2% were female and 61.5% were admitted with infection. The mean APACHE II score was 19.7, 46.2% had acute renal dysfunction, 67.3% received inotropics/ vasopressors, 27.9% pulmonary artery catheter and 74% invasive mechanical ventilation. The mean length of stay in ICU was 18.5 days and mortality rate was 32.7%. In the univariate logistic regression analysis, factors associated with mortality were high APACHE II score, use of inotropics/vasopressors, pulmonary artery catheter and invasive mechanical ventilation. High APACHE II score and use of inotropics/vasopressors remained significant in the multi-variate analysis. The area under the receiver operating characteristic curve of the APACHE II score to predict mortality was 0.689 (95% CI 0.586-0.791 p = 0.002) and the Hosmer- Lemeshow chi( 2) was 5.094 (p = 0.747). We conclude that the mortality rate in patients with SLE admitted to the ICU is high. The most common cause of admission was infection. The factors associated with mortality were high APACHE II score and the use of inotropics/vasopressors. APACHE II score was unable to accurately predict mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19850662     DOI: 10.1177/0961203309345720

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

Review 1.  [Rheumatic patients in the intensive care unit].

Authors:  P Lehmann; T Brünnler; B Salzberger; M Fleck
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

2.  Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Authors:  Alimohammad Fatemi; Somayeh Shamsaee; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

Review 3.  The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.

Authors:  Xiaoyan Zhang; Ling Ji; Lichuan Yang; Xiaohong Tang; Wei Qin
Journal:  Int Urol Nephrol       Date:  2016-01-19       Impact factor: 2.370

4.  Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study.

Authors:  Yael Haviv-Yadid; Yulia Segal; Amir Dagan; Kassem Sharif; Nicola Luigi Bragazzi; Abdulla Watad; Howard Amital; Yehuda Shoenfeld; Ora Shovman
Journal:  Clin Rheumatol       Date:  2019-06-26       Impact factor: 2.980

Review 5.  Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know.

Authors:  Mohanned Mustafa; Easwaradhas Gladston Chelliah; Michael Hughes
Journal:  Rheumatol Int       Date:  2018-03-16       Impact factor: 2.631

6.  Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children.

Authors:  Georges Ja Casimir; Fabienne Heldenbergh; Laurence Hanssens; Sandra Mulier; Claudine Heinrichs; Nicolas Lefevre; Julie Désir; Francis Corazza; Jean Duchateau
Journal:  J Inflamm (Lond)       Date:  2010-06-02       Impact factor: 4.981

7.  Risk factors for and prediction of mortality in critically ill medical-surgical patients receiving heparin thromboprophylaxis.

Authors:  Guowei Li; Lehana Thabane; Deborah J Cook; Renato D Lopes; John C Marshall; Gordon Guyatt; Anne Holbrook; Noori Akhtar-Danesh; Robert A Fowler; Neill K J Adhikari; Rob Taylor; Yaseen M Arabi; Dean Chittock; Peter Dodek; Andreas P Freitag; Stephen D Walter; Diane Heels-Ansdell; Mitchell A H Levine
Journal:  Ann Intensive Care       Date:  2016-02-27       Impact factor: 6.925

8.  Factors Associated with Mortality in Patients with Autoimmune Diseases Admitted to the Intensive Care Unit in Bogota, Colombia.

Authors:  Jorge Armando Carrizosa; Jorge Aponte; Diego Cartagena; Ricard Cervera; Maria Teresa Ospina; Alexander Sanchez
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

9.  Mortality of Sepsis in Patients With Rheumatoid Arthritis: A Single-Center Retrospective Analysis and Comparison With a Control Group.

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2020-04-06       Impact factor: 3.510

10.  Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.

Authors:  Jin-Min Peng; Bin Du; Qian Wang; Li Weng; Xiao-Yun Hu; Chan-Yuan Wu; Yan Shi
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.